Regional Manager - Prenatal, LA North at BillionToOne

Los Angeles, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Diagnostics, BiotechnologyIndustries

Requirements

Minimum 4+ years of field sales management experience leading a team of sales reps at a molecular diagnostics/genetics company required, specifically out of Women’s Health, Prenatal, and/or Reproductive Health selling directly to OBGYNs, MFMs, GCs throughout the LA North region, with an existing portfolio of convertible client relationships
Strong experience hiring, developing, coaching, and motivating a team of sales reps to exceed ambitious sales goals
Demonstrated successful sales track record (e.g., multiple award winning - President’s Club, Chairman’s Club, Circle of Excellence or equivalent), solid negotiation and closing skills, strong data analysis skills, understanding of buyer/decision maker types, exhibit effective selling, listening, presentation skills, strong focus on pull through, and good follow through skills
Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and external customers
Effective time management skills required with a demonstrated ability to assess and prioritize opportunities
Exceptionally bright, flexible, self-motivated and results oriented with strong interpersonal and analytical skills and the ability to think strategically as well as execute tactically
Must act with a sense of urgency, with a focus on closing business
Ability to assess the needs of OBGYNs & MFMs and their office staff with a focus on consultative sales, coordination of logistics, and problem solving

Responsibilities

Develop a comprehensive, data-driven sales strategy and business plan to build and grow market development throughout the LA North region
Build and lead a team of talented, high performing sales reps in the execution of sales strategies and optimization of opportunities to increase profitability and market share
Recruit, Hire, Train, Manage, and Develop representatives
Develop and enhance customized pitches to individual OBGYNs, MFMs, and prenatal Genetic Counselors
Use data to analyze sales results, identify industry trends, and stay abreast of competition to increase sales volume and drive success within territory

Skills

Sales Management

Direct Sales

Women's Health

Prenatal Diagnostics

Reproductive Health

Sales Strategy

Business Planning

Market Development

Team Leadership

OBGYN Sales

NIPT

MFM

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free